Surface glycoconjugates play important roles in the infectious cycle of Leishmania major, including the abundant lipophosphoglycan (LPG) implicated in parasite survival in the sand fly vector and the initial stages of establishment in the mammalian host macrophage. We describe a system for inducible expression of LPG, applying a novel protein-based system that allows controlled degradation of a key LPG biosynthetic enzyme, UDP-galactopyranose mutase (UGM). This methodology relies on a mutated FK506-binding protein (FKBP) destabilizing domain (dd) fused to the protein of interest; in the absence of rapamycin analogs, such as Shld1, the dd domain is destabilized, leading to proteasomal degradation, whereas drug treatment confers stabilization. Tests in L. major using dd fusions to a panel of reporters and cellular proteins confirmed its functionality, with a high degree of regulation and low background, and we established the kinetics of protein activation and/or loss. Two inexpensive and widely available ligands, FK506 and rapamycin, functioned similarly to Shld1, without effect on Leishmania growth or differentiation. We generated parasites lacking UGM through deletion of the GLF gene and substitution with a ddGLF fusion construct, either as chromosomal knockins or through episomal complementation; these showed little or no LPG expression in the absence of inducer, whereas in its presence, high levels of LPG were attained rapidly. Complement lysis tests confirmed the correct integrity of the Leishmania LPG coat. These data suggest that the dd approach has great promise in the study of LPG and other pathways relevant to parasite survival and virulence.
Surface glycoconjugates play important roles in the infectious cycle of Leishmania major, including the abundant lipophosphoglycan (LPG) implicated in parasite survival in the sand fly vector and the initial stages of establishment in the mammalian host macrophage. We describe a system for inducible expression of LPG, applying a novel protein-based system that allows controlled degradation of a key LPG biosynthetic enzyme, UDP-galactopyranose mutase (UGM). This methodology relies on a mutated FK506-binding protein (FKBP) destabilizing domain (dd) fused to the protein of interest; in the absence of rapamycin analogs, such as Shld1, the dd domain is destabilized, leading to proteasomal degradation, whereas drug treatment confers stabilization. Tests in L. major using dd fusions to a panel of reporters and cellular proteins confirmed its functionality, with a high degree of regulation and low background, and we established the kinetics of protein activation and/or loss. Two inexpensive and widely available ligands, FK506 and rapamycin, functioned similarly to Shld1, without effect on Leishmania growth or differentiation. We generated parasites lacking UGM through deletion of the GLF gene and substitution with a ddGLF fusion construct, either as chromosomal knockins or through episomal complementation; these showed little or no LPG expression in the absence of inducer, whereas in its presence, high levels of LPG were attained rapidly. Complement lysis tests confirmed the correct integrity of the Leishmania LPG coat. These data suggest that the dd approach has great promise in the study of LPG and other pathways relevant to parasite survival and virulence.
inducible expression ͉ FK506 ͉ glycoconjugates ͉ pathogen ͉ trypanosomatid protozoa L eishmaniasis is a parasitic disease infecting more than 12 million people worldwide and constituting a significant public health burden in affected areas (1) . It is caused by protozoan parasites of the genus Leishmania that, depending on the species, cause a range of pathologies, from cutaneous or mucocutaneous to the fatal visceral leishmaniasis. Since the emergence of reverse genetic approaches, including homologous gene replacement and heterologous expression, our ability to probe gene function and expression related to parasite virulence has advanced considerably (2, 3) . Nonetheless, the Leishmania toolkit would benefit from further development incorporating methods better able to cope with challenges arising from the diploid nature of the Leishmania genome, as well as research into the limitations of current regulatable systems, which are typically based on various strategies affecting transcriptional initiation (4) . These face some challenges because of the unique aspects of transcription and gene expression in trypanosomatid protozoans (5, 6) .
Protein-based regulatable systems offer some potential for overcoming limitations arising from regulatable transcription systems. Recently, Wandless and colleagues described a system in which protein levels are controlled through regulated degradation of a cis-acting domain joined to the target protein of interest (7) . The destabilizing protein domain consists of a modified, 108-aa FK506/ rapamycin-binding protein (FKBP) engineered to bind selectively to the nontoxic FK506/rapamycin analog, Shld1. In the presence of Shld1, the FKBP destabilization domain (dd) is properly folded, thereby conferring stability to the dd fusion protein, whereas in its absence, destabilization of the dd structure targets the protein for degradation. This method was applied recently to the Apicomplexan parasites Plasmodium falciparum and Toxoplasma gondii (8, 9) , and here we report success with 2 species of Leishmania parasites. Of practical importance, the relative insensitivity of Leishmania to FKBP ligands, including rapamycin and FK506, allows them to be used in vitro, advantageous because of their lower cost and widespread availability.
We applied this to the development of regulated expression of a key Leishmania virulence molecule, lipophosphoglycan (LPG). The cell surface of Leishmania is densely covered with a variety of glycoconjugates playing major roles throughout the parasite's life cycle (10) . One of the most intensely studied is the abundant LPG, consisting of a long phosphoglycan chain of galactose-mannosephosphate-based repeating units attached to the plasma membrane through a GPI anchor (11). In L. major, LPG plays a role in the establishment of the infection of promastigotes in the sand fly vector, acting as an adhesin that promotes attachment of the parasites to the insect midgut wall through binding to a galectin receptor (12) . After inoculation of the parasite into the mammalian host by the sand fly bite, LPG plays important roles in the establishment of the infection by conferring resistance to lysis by complement, protection from oxidative damage, and remodeling of the initial phagolysome, including the induction of a transient delay in phagolysosomal fusion (13) (14) (15) . The roles of LPG deduced by a variety of biochemical and cellular studies have been supported by studies of mutant parasites lacking genes of the LPG biosynthetic pathway (13, (16) (17) (18) (19) .
LPG is assembled through a series of steps involving a diverse set of proteins located in cellular compartments, including the cytosol, glycosome, and secretory pathways (11, 20) . A key linkage within the LPG core involves galactosylfuranose (Galf ), an unusual parasite sugar not made by the mammalian host (21, 22) . The precursor for Galf is UDP-Galf, which arises from the action of cytosolic UDP-galactopyranose mutase (UGM, encoded by the gene GLF) (16, 23) , and glf Ϫ knockouts confirm the requirement for this gene in Leishmania LPG biosynthesis (18) . Although Galf occurs on other Leishmania glycoconjugates, including the abundant glycosylinositolphosphatidylinositols (GIPLs), previous studies establish that GIPLs play little role in L. major infectivity (24) and, accordingly, glf Ϫ knockouts show phenotypes identical to lpg1 Ϫ parasites lacking LPG alone (18, 19, 25) . In this work, we used the dd fusion approach to regulate LPG expression through control of UGM levels, yielding parasites that when placed in the ''on'' and ''off'' states closely resemble WT and LPG-deficient mutants.
Results
The Modified FKBP dd Is Functional in L. major. Preliminary tests suggested that the stabilizing ligand Shld1 had little toxicity to L. major at 1 M. We expressed a dd yellow fluorescent protein (ddYFP) in L. major after integration of constructs into the SSU ribosomal locus (SSU::IR1PHLEO-ddYFP) and compared it to YFP expression in similar independent transfectants (SSU::IR1PHLEO-YFP). Parasites expressing unmodified YFP were highly fluorescent [62 fluorescence units (FU)], whereas those expressing ddYFP were only slightly more fluorescent than untransfected controls (9 vs. 7 FU; Fig. 1 A and B) . Notably, addition of 1 M Shld1 to the ddYFP-expressing Leishmania for 24 h yielded strongly fluorescent parasites (Ϸ150 FU), 16-fold greater than seen in the absence of ligand (62-fold after correcting for background fluorescence; Fig. 1 A and B) . Similar results were obtained with ddYFP expressed from multicopy episomal vectors. We tested a cytosolic dd-Luciferase (ddLUC) construct after expression in L. major. In the absence of Shld1, ddLUC transfectants showed minimal luminescence, close to the WT background (1.0 ϫ 10 4 vs. Fig. 2A , Table S1 ). We then tested ddYFP expression after growth of ddYFP-expressing L. major for 24 h in the presence of 1 M ligand (Fig. 1B ). FK506 and rapamycin induced strong YFP fluorescence in ddYFP-expressing L. major, slightly higher than seen with Shld1 (Fig. 1B) . Similarly, FK506 and rapamycin induced high levels of LUC expression in ddLUC expressing L. major-200-fold and 250-fold that seen in the absence of ligand (Fig. 1C) . Dose-response curves were performed for all 3 compounds by using the ddYFP-expressing L. major and 24 h of induction (Fig.  2B) . Shld1 was the most potent, with an effective concentration (EC 50 ) of 10 nM, followed by rapamycin (60 nM) and FK506 (200 nM). As seen in previous studies, ddYFP expression was ''tunable,'' in that variation in ligand concentration yielded variation in the average YFP fluorescence homogeneously within the cell population (Fig. S1 A) . The concentration required for maximal ddYFP expression was 250 nM for Shld1 and 1 M for FK506 and rapamycin (Fig. 2B) . At 1 M ligand, neither parasite growth nor differentiation to the infective metacyclic form was affected ( Fig.  2 A and Fig. S1B ).
Kinetics of ddFKBP-Controlled Induction and Loss in L. major. Early log-phase promastigotes were treated with different concentrations of stabilizing compounds, and ddYFP expression was assessed by flow cytometry for 24 h. Maximum ddYFP protein levels were achieved within 8 h for all 3 drugs, with similar kinetics (Fig. 3 A-C) .
To study decay, parasites were incubated 24 h with ligand, and then were washed once and inoculated into fresh media. More than 2 h after removal of Shld1 and FK506, ddYFP expression had decreased to nearly basal levels, with a half-life of about 30 min (Fig.   Fig. 1 . Functionality of the FKBP dd system in L. major. WT, YFP-expressing, ddYFP-expressing, or ddLUC-expressing promastigotes were grown in the presence or absence of 1 M Shld1, FK506, and rapamycin for 24 h, and fluorescence levels were measured by flow cytometry (A and B) or luciferase activity assay (C). 
D-F).
The decay of ddYFP expression was slower after rapamycin treatment, reaching basal levels after more than 4 h and with a decay half-life of about 75 min (Fig. 3 D and E) . Western blot analysis with anti-GFP antibody, which also recognizes YFP, confirmed these findings (Fig. S2 ). As summarized in Table S1 , when used at 1 M, FK506 and rapamycin can be used effectively as FKBP dd stabilizing ligands in Leishmania.
Application of the ddFKBP System to Leishmania Proteins and in
Leishmania braziliensis. We generated dd fusions for a variety of L. major proteins, including DHCH1 (5,10-methylenetetrahydrofolate dehydrogenase/5,10-methenyltetrahydrofolate cyclohydrolase), FTL (formate-tetrahydrofolate ligase), and DHFR-TS (dihydrofolate reductase thymidylate-synthase). Each fusion protein was expressed in L. major, and its levels were determined by Western blotting after 24 h in the presence or absence of inducer. For each protein, strong regulation was seen in orders of magnitude similar to those seen for the reporter proteins. In the absence of inducer, expression of the fusion protein was negligible at the conditions tested (Fig. S3A) . Similar results were obtained with ddYFP, ddLUC, ddFTL, or ddDHCH1 proteins expressed in promastigotes of L. braziliensis, an early-diverging species belonging to the subgenus Viannia ( Fig. S3 B and C) . These results suggest that the ddFKBP fusion approach will have broad applicability in Leishmania.
Generation of an L. major Mutant Lacking LPG Through Ablation of
Galf Synthesis. We generated a glf Ϫ null mutant (formally, glf⌬HYG/ glf⌬PAC) by standard techniques of gene replacement ( Fig. 4 and Fig. S4A ), which requires 2 successive rounds of targeting because Leishmania is predominantly diploid (30) . Generation of the correct planned replacements and loss of GLF were confirmed by PCR (Fig. S4B ). Western blotting with the monoclonal antibody WIC79.3, which recognizes the galactose-containing side chains of LPG and other phosphoglycans, showed that the glf Ϫ parasites lacked LPG (Fig. S4C ) but retained expression of the highmolecular weight proteophosphoglycans (PPGs), which lack Galf (20) . In contrast, control mutant lpg2 Ϫ , lacking the Golgi GDPmannose transporter required for the synthesis of all phosphoglycans, showed loss of both LPG and PPG (Fig. S4C ). These findings agree with previous work using another L. major glf Ϫ strain (18) .
Complementation of L. major glf ؊ with ddUGM Confers Regulatable
LPG Expression. A ddUGM fusion protein was expressed in the glf Ϫ mutant by transfection with a multicopy episomal vector, pIR1PHLEO-ddGLF (Fig. 4) . glf Ϫ /ϩpIR1PHLEO-ddGLF transfectants were grown in the presence or absence of 1 M FK506 for 24 h, and the levels of ddUGM protein were assessed by Western blotting. Some variations in basal LPG and/or ddUGM induction were seen in these transfectants that were attributed to differences in copy number of the episomal vector (Fig. S5) .
Dose-response studies for several clonal lines showing minimal basal LPG and ddUGM expression were performed (one is shown in Fig. 5A ). In the absence of Shld1, a low level of LPG expression was found, whereas addition of just 10 nM Shld1 resulted in strong LPG expression without detectable expression of ddUGM protein, suggesting that very low protein levels are required for LPG synthesis. WT levels of LPG were attained at just 50 nM Shld1 (Fig. 5A ).
Knockin Approaches Yield Improvements in ddGLF-Dependent LPG Down-Regulation. The utility of regulatable systems is ultimately dependent on their ability to cross biologically relevant thresholds 4 . Generation of glf Ϫ mutants expressing ddUGM from multicopy episomes or chromosomal knockins. L. major LV39cl5 parasites were transfected with a construct replacing the GLF ORF of the first allele with that encoding a hygromycin B resistance marker (HYG). This heterozygous line (ϩ/glf⌬HYG) was used in 2 ways. As depicted on the left branch, the remaining GLF allele was replaced with that encoding a puromycin resistance marker (PAC), yielding a homozygous glf Ϫ null mutant (formally, glf⌬HYG/glf⌬PAC). GLF was then restored by transfection with pIR1PHLEO-ddGLF, yielding glf Ϫ /pIR1PHLEO-ddGLF parasites. Alternatively, as depicted in the right branch, the remaining GLF allele in ϩ/glf⌬HYG was replaced by transfection with a PHLEO-ddGLF knockintargeting construct, yielding glf⌬HYG/ddGLF. distinguishing WT and mutant phenotypes. However, expression levels from most common Leishmania vectors are considerably higher than those of chromosomal genes as a result of being multicopy episomes or from integration into the rRNA locus (31, 32) . Thus, overexpression of a destabilized protein might leave protein levels high enough to fulfill normal function, perhaps accounting for the residual LPG expression evident in the studies above employing episomal ddUGM vectors. To test this, we generated a chromosomal knockin line expressing a single copy of ddUGM from the normal GLF locus.
We first created a generic knockin cassette that consists of a phleomycin resistance ORF (PHLEO) followed by a Leishmania intergenic region driving expression of the dd domain (Fig. S6A) . This was then flanked on the 5Ј side with 915 bp of the 5Ј GLF flanking region and on the 3Ј side with the 1.5-kb GLF ORF (Fig.   S6B ). This fragment was transfected into a heterozygous line bearing an HYG replacement of one GLF allele, followed by selection for HYG and PHLEO (Fig. 4) . Several clones glf⌬HYG/ ddGLF were obtained with integration of the PHLEO-ddGLF cassette in the correct genomic locus (Fig. S6C ), referred to here as ddGLF knockin lines.
Importantly, LPG levels were undetectable in the ddGLF knockin line cells grown in the absence of FK506 for 48 h (Fig.  5B, lane 3) , in contrast to residual basal levels found in the glf Ϫ /ϩpIR1PHLEO-ddGLF transfectants (Fig. 5A, lane 3, and  Fig. S6D ). Western blotting revealed that in the presence of 1 M FK506, ddUGM levels were Ϸ10-fold lower in the ddGLF knockin lines compared with the glf Ϫ /ϩpIR1PHLEO-ddGLF transfectants (Fig. S6D) , as predicted. Thus, reduction in the levels of ''destabilized'' UGM by the knockin strategy resulted in improved down-regulation of LPG levels. Although some clonal variability was evident, as seen before, in 5 clones the LPG levels after induction were fully restored to WT levels (Fig. 5B , WT lane 1 vs. lane 6 or 7).
Kinetics of ddUGM-Dependent LPG Induction and Loss. Similar to many eukaryotic glycoconjugates, LPG synthesis occurs in the Golgi, followed by trafficking to the cell surface, where it is continuously ''shed'' with a half-life of about 3-7 h (33, 34). Thus, we examined the effects of regulated UGM expression on the kinetics of LPG acquisition and loss because this will affect its utility in functional studies of LPG. The kinetics of Shld1 stabilization of ddUGM appeared to be somewhat less rapid than seen with ddYFP reporter, with maximum ddUGM expression requiring 24 h of incubation with FK506. The appearance of LPG appeared to mirror ddUGM accumulation (Fig. 5C ). The ddUGM levels dropped to near-basal levels 4 h after removal of FK506. In contrast, LPG levels fell more slowly, with a 3-fold decrease after 8 h, and complete loss of LPG was achieved 24 h after FK506 withdrawal ( Fig. 5 B and C) . Thus, after ddUGM destabilization, LPG levels are lost from a cell more slowly than ddUGM, at rates similar to the rate of shedding established in previous studies.
ddUGM-Dependent LPG Synthesis Recapitulates Expected Complement Sensitivities. The Leishmania surface is highly sensitive to perturbations involving loss and/or overexpression of many surface molecules, including LPG, gp46 and gp63, and the SHERP/HASP family, as judged by increased sensitivity to lysis by complement (19, (35) (36) (37) . We used this assay to probe the faithfulness of the ddUGMdependent LPG regulatory system to modulate the parasite surface. glf Ϫ mutants were highly susceptible to lysis by complement (Fig.  6A) , as seen in other LPG-deficient mutants (19) .
The glf Ϫ /ϩpIR1PHLEO-ddGLF transfectants grown in the presence of FK506 were completely protected from lysis by complement (Fig. 6B) , as expected given their strong LPG expression (Fig. 5A) . However, in the absence of ligand most parasites (64%) remained complement-resistant, suggesting that the low LPG levels present in these cells were nonetheless sufficient to preclude lysis. This may reflect heterogeneity in the cellular population, most likely arising from variation in plasmid copy number.
Consistent with their high LPG levels, the knockin ddGLF parasites were highly resistant to complement in the presence of FK506 inducer. Importantly, in the absence of FK506 they became highly susceptible to complement lysis, similar to the glf Ϫ control (Fig. 6C) and consistent with the absence of LPG (Fig. 5B) . As noted earlier, clonal variability was evident, with many lines showing an intermediate phenotype.
Discussion
Here, we investigated the functionality of a recently developed system to regulate protein levels that consists of tagging the protein of interest with an FKBP dd, which in the absence of a stabilizing ligand (Shld1, rapamycin, or FK506) is targeted to degradation by the proteasome (7). We show that this system performs as well as, and in some respects better than, that described in mammalian cells or Apicomplexan parasites (8, 9) . The FKBP/Shld1 system functioned well in 2 Leishmania species representing different subgenera, and it conferred strong liganddependent expression for all 4 parasite proteins tested ( Fig. 1 and  Fig. S3 ). The kinetics of induction and degradation were also favorable, with full induction occurring within 8 h and loss occurring within 2 h of drug removal ( Fig. 3 and Table S1 ). Lastly, the utility of the system was shown by its ability to regulate expression of the important surface glycoconjugate LPG (Fig. 5) .
Hence, the ddFKBP system constitutes a promising molecular tool for the regulation of protein levels in L. major, with relatively fast effects on protein levels upon addition and removal of rapamycin analogs. A second advantage arises from the property termed ''tunability,'' in that the level of expression can be adjusted quantitatively and homogeneously across the cell population by titration of varying amounts of ligand (Fig. S1 A) (7) .
Rapamycin and FK506 Are Cost-Effective Ligands for the dd-Inducible
System in Leishmania. Although Shld1 is nontoxic to cells from many species tested in vitro thus far, and to mice as well, it is relatively expensive and of limited availability. Shld1 was 10-fold more potent in stabilization of the ddYFP fusion protein in L. major than reported for mammalian cells (Fig. 2B and Table S1) (7). Although alternate FKBP ligands, such as rapamycin and FK506, are relatively inexpensive and available, in many species they show toxicity due to inhibition of critical signaling pathways involving calcineurin and TOR kinases (38) (39) (40) . However, Leishmania were relatively insensitive to FK506 and rapamycin (IC 50 : 7.7 and 4.9 M), and full induction of ddYFP or ddLUC expression was achieved by 1 M (Figs. 1 and 2 and Table S1 ).
The potent, efficacious properties of FK506 and rapamycin with the ddFKBP system in Leishmania, in combination with their relative lack of toxicity in vitro, establish these as attractive alternatives to the more costly Shld1. Potentially, these ligands may be used in other organisms, depending on the relative potency of ddFKBP induction vs. toxicity. Although FK506 is highly toxic to mammalian cells, rapamycin has been used productively in mice in vivo (41) . However, it seems likely that their immunosuppressive properties may prove problematic because of the complex interactions of Leishmania parasites and their host immune system (42).
An Inducible System for LPG Expression. Expression of a ddUGM construct within the glf Ϫ mutant resulted in low levels of LPG in the absence of ligand, but full LPG expression upon induction (Fig. 5) . Robust LPG expression was induced at the lowest concentration of Shld1 tested (10 nM), at least 20-fold lower than required to get maximal ddUGM expression (Fig. 5A) . Remarkably, the low residual levels of LPG expression in the uninduced glf Ϫ / ϩpIR1PHLEO-ddGLF line were sufficient to confer considerable resistance to lysis by complement, a sensitive, functional readout. Thus, we tested an alternative strategy, generating a ddGLF knockin at the normal GLF locus. As expected, the ddGLF knockins showed 10-fold lower levels of ddUGM expression in the presence of ligand compared with the ddGLF episomal complemented line. Importantly, these showed undetectable ddUGM and LPG levels in the absence of ligand and were completely susceptible to complement lysis. In contrast, in the presence of ligand, LPG levels and complement resistance closely resembled that of WT parasites (Figs. 5 and 6 ). Together, these data confirm the biochemical and phenotypic ''faithfulness'' of the inducible system in its on and off states.
We anticipate that this inducible system will prove valuable in further studies of the diverse roles of LPG in survival of the Leishmania parasite. These studies will need to take into account the kinetic properties of both ddUGM-dependent LPG synthesis and LPG shedding described here. LPG-dependent Leishmania interactions with its mammalian host take place rapidly after deposition by the sand fly vector, within a few minutes (complement lysis, macrophage uptake) to hours (inhibition of phagolysosomal fusion, differentiation), and are completed within 24 h, when the parasites have successfully established infection as amastigotes, which lack LPG (15, 43) . The kinetics of ddUGM-dependent LPG appearance and loss, requiring upwards of 4 h for the significant gain or loss, may render its use in these settings problematic. Nonetheless, the tunability of the ddFKBP system would permit studies of the quantitative dependency of LPG levels under these circumstances. In contrast, the role of LPG in the sand fly vector should be amenable to study by the ddUGM system, because these LPG-dependent interactions span days, including initial survival within the peritrophic matrix-enclosed blood meal, binding of procyclics to the parasite midgut lectin PpGalec, and release as infective metacyclics (43) .
We anticipate more generally that the properties of the ddFKBP regulatory system described here will be applicable to the study of many other parasite proteins in a variety of circumstances relevant to the parasite infectious cycle. Our studies identify several important variables to consider in the design of such strategies. First, as seen in other systems, there can be significant variation among clonal lines, the origins of which are not always evident, suggesting that screening at both the biochemical and biological levels for lines behaving properly will be required. Second, it remains to be determined whether the destabilization module will function effectively in cellular compartments other than the cytoplasm; for example, the secretory pathway or organelles, such as the glycosome or mitochondrion. Lastly, it is clear that genetic strategies that minimize the level of expression of the protein in the uninduced state-for example, using knockin rather than episomal or highlevel expression vectors-may have the highest probability of crossing biologically relevant thresholds in the off state. 
Materials and Methods
FKBP dd Ligands. Shld1 was generously provided by Thomas Wandless (Stanford University, Stanford, CA). Rapamycin and FK506 were purchased from LC Laboratories.
Parasites. L. major
Friedlin clone V1 (MHOM/IL/81/Friedlin) and LV39 clone 5 (Rho/SU/59/P) were grown in M199-based medium (31) . L. braziliensis (MHOM/ BR/75/M2903) was grown in Schneider's Insect Medium (Sigma-Aldrich) supplemented with 10% heat-inactivated FBS, 2 mM L-glutamine, 500 units of penicillin, and 50 g/mL streptomycin. Metacyclics were isolated by negative selection using peanut-agglutinin (PNA) (44) .
Unless otherwise indicated, all experiments were performed with promastigotes during early to mid log phase of exponential growth (typically Ͻ8 ϫ 10 6 parasites per milliliter) because some proteins are extensively degraded in stationary phase because of the activation of a lysosomal pathway (45) . These include YFP and GFP but not DsRed2 or Luciferase.
DNA Constructs and Genetic Manipulation of Parasites.
The description of the molecular constructs used in this work is presented in Figs. S5C and S6A , Table  S2 , and Table S3 . DNAs were introduced directly or after digestion with appropriate restriction enzymes, followed by dephosphorylation. Transfection was performed by using high-voltage electroporation (46) , and clonal transfectants were recovered after plating on semisolid media containing 1% agar, which contained the appropriate concentrations of selective drugs.
Flow Cytometry, Luciferase Assay, and Western Blotting. YFP expression was determined by flow cytometry using a FACSCalibur cytometer (Becton Dickinson) and quantitated by using CellQuest software (BectonDickinson). Luciferase activity was determined by suspending 10 6 cells in 200 L of M199 medium in a 96-well plate containing 1 L of luciferin (30 g/mL). After 10 min of incubation, the plate was imaged by using a Xenogen IVIS Photoimager, and luciferase activity was quantified as photons per second (p/s). Preparation of samples for Western blotting and the antisera used are described in SI Text.
Complement Lysis Assay. Lysis by complement was assayed as described previously (19) . Briefly, late log-phase promastigotes were washed once in DMEM, and 1 ϫ 10 6 washed cells were then incubated at room temperature for 30 min with 4% human serum in DMEM containing 0.4 g/mL propidium iodide (PI), followed by flow cytometry.
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Western Blot Analysis. Promastigote lysates were prepared by suspending parasites rapidly in 1ϫ Laemmli loading buffer and immediately boiling for 5 min. Samples (2 ϫ 10 6 cell equivalents per lane) were subjected to SDS/PAGE and electrotransferred to nitrocellulose membranes (Hybond-ECL; Amersham Biosciences). Membranes were blocked with 5% nonfat dry milk in TBST (20 mM Tris-base, pH 7.6; 140 mM sodium chloride; and 0.05% Tween 20) for 1 h at room temperature. Protein loading was assessed with a rabbit anti-L. major histone H2A polyclonal antibody at 1:100,000 dilution. Polyclonal rabbit antibody anti-GFP (Abcam) was used at 1:2,500 dilution, and anti-FKBP12 (Affinity BioReagents) was used at 1:1,000 dilution; monoclonal antibody WIC79.3 (1) was used at 1:2,000 dilution. Goat antirabbit IgG HRP-conjugated secondary antibody (Jackson ImmunoResearch) was used at 1:10,000; anti-mouse IgG HRPconjugated secondary antibody (Amersham Biosciences) was used at 1:5,000. ECL reactions were revealed with a PerkinElmer Life Sciences chemiluminescence kit. Quantitative Western blotting with WIC79.3 was performed with the Odissey Infrared Imaging System (LI-COR Biosciences) using the manufacturer's blocking buffer and goat anti-mouse IRDye 800CW secondary antibody (Li-Cor Biosciences). Quantitation was done with the Multi Gauge V3.0 software (Fujifilm).
ddFKBP Constructs. The oligonucleotides, templates, vectors, and constructs used or developed are described briefly below and with more detail in Table S2 and Table S3 . All relevant regions of each construct were confirmed by sequencing and/or functional assays.
ORFs of interest were amplified by PCR and inserted into pGEM-T-Easy (Promega) by TA cloning according to the manufacturer's instructions. The YFP and ddYFP ORFs were then inserted into the Leishmania expression vector pIR1PHLEO (strain B4054) directly after digestion with BamHI, yielding pIR1PHLEO-ddYFP (strain B6145) and pIR1PHLEO-YFP (strain B6146).
To generate a general plasmid as an entry expression vector to fuse other genes of interest with the destabilizing domain, we amplified the ddFKBP segment with primers SMB3250 and SMB3251 and inserted the fragment in pGEM-T-Easy to generate pGEM-ddFKBP (strain B6177). The ddFKBP fragment was released by digestion with BclI plus BglII (by using a plasmid preparation obtained with a dam-Escherichia coli strain, SCS110) and ligated in the BamHI site of pIR1PHLEO, generating pIR1PHLEO-ddFKBP (strain B6182), which has convenient unique BamHI, SpeI, and XbaI sites into which ORFs can be inserted in frame (Fig. S5C) . ORFs from the reporter luciferase (amplified from pGL3 Basic from Promega, which lacks the peroxisome-targeting C-terminal tripeptide) and several L. major genes (FTL: LmjF30.2600; DHCH1: LmjF26.0320; DHFRTS: LmjF06.0860; GLF: LmjF18.0200) were inserted into the BamHI site of B6182 to create pIR1PHLEO-ddFTL (strain B6247), pIR1PHLEO-ddDHCH (strain B6227), pIR1PHLEO-ddDHFRTS (strain B6332), and pIR1PHLEO-ddGLF (strain B6308) (Table S3) .
Targeted Gene Replacement of L. major GLF. The 5Ј GLF flanking region was amplified by PCR from L. major LV39 genomic DNA with primers SMB2188 and SMB2189, and the amplicon was digested by SalI plus SpeI and inserted into similarly digested pT7Blue (Novagen), generating plasmid B5327. The 3Ј GLF flanking region was amplified by PCR with oligonucleotides SMB2190 and SMB2191, digested with SpeI plus KpnI, and inserted into similarly digested B5327, generating plasmid B5352. The HYG and PAC ORFs were then inserted between the internal SpeI/BamHI sites of B5352, yielding the desired GLF replacement constructs (B5356 and B5357, respectively). These constructs were digested with HindIII plus KpnI to yield the appropriate targeting fragment before transfection.
The first GLF allele was inactivated by using the GLF::HYG targeting construct. L. major LV39 clone 5 (Rho/SU/59/P) promastigotes were transfected by electroporation (2) , and clonal transfectant lines were recovered after plating on 50 g/mL hygromycin B. Multiple clonal lines showing the expected replacement by appropriate PCR tests were identified (GLF/GLF::⌬HYG). Several of these were infected into susceptible BALB/c mice at high inoculums (10 7 ). These showed lesion development typical of WT parasites, and after 1 month parasites were recovered. Clone H1 was chosen for targeting of the remaining GLF allele with the GLF::PAC replacement construct, and transfectants were recovered after plating on semisolid media containing 20 g/mL puromycin and 50 g/mL hygromycin B. Several clones were analyzed with regard to correct integration of the replacement cassette and the lack of the GLF ORF by PCR. Several homozygous replacements were obtained, and one of these was chosen for future work (⌬GLF::HYG/⌬GLF::PAC clone H1P1, referred to as glf Ϫ hereafter). This line was then transfected with pIR1PHLEO-ddGLF, yielding glf Ϫ /ϩpIR1PHLEO-ddGLF, which expresses the ddGLF from the multicopy episomal pIR1PHLEO vector.
Generation of Knockin ddGLF L. major. To facilitate construction of ddFKBP knockin constructs, we created a generic ddFKBP knockin cassette with 3 key elements: a drug resistance marker (PHLEO), the DST gene intergenic region (DST IR), which has been extensively used to drive expression of downstream genes in Leishmania (3), and the ddFKBP sequence (strain B6323). We first digested pGEM-ddFKBP (strain B6177) with BclI plus BglII to release the ddFKBP fragment and ligated it in the BamHI site of pXGPHLEO (strain B3324), generating pXGPHLEOddFKBP (strain B6319). This plasmid was then used as template in PCR amplification with primers SMB2563 and SMB3251 to obtain the PHLEO-DST-ddFKBP fragment, which was cloned in pGEM-T-Easy, yielding pGEM-PHLEO-DST IR-dd (strain B6323; Fig. S6A ). This is a generic knockin cassette; for any given gene of interest (GOI), it is necessary to insert the 5Ј flanking sequence of the GOI ORF upstream of the PHLEO resistance marker (site A) and insert the ORF of the GOI in frame with the ddFKBP sequence (site B) (Fig. S6A) .
To create the ddGLF knockin fragment, we released the 5Ј flank of GLF used previously in the knockout cassette (strain B5327) with SalI plus SpeI digestion and inserted it into pGEM-PHLEO-DST IR-dd (strain B6323), which had been digested similarly, generating pGEM-5ЈUTR GLF-PHLEO-DST IR-dd (strain B6331). Finally, we inserted the ORF of GLF in the BamHI of B6331 in frame with the ddFKBP sequence, creating pGEM-kiddGLF (strain B6336). This targeting construct was released after digestion with NdeI plus SacII and was dephosphoryated before use.
The heterozygous L. major ϩ/glf⌬HYG mutant clone H1 above was transfected with the knockin cassette by electroporation, and parasites were plated on semisolid M199 medium agar plates containing 50 g/mL hygromycin, 10 g/mL phleo-mycin, and 2 M FK506 to maintain ddGLF activity. Several colonies were picked and grown in liquid medium with 50 g/mL hygromycin, 10 g/mL phleomycin, and 1 M FK506; correct integration of the cassette in the transfectants was verified by PCR. Parasites were cultivated in the presence of 1 M FK506 at all times unless otherwise indicated. , a general Leishmania expression vector that can be used to tag GOIs with an N-terminal ddFKBP. This vector may be used to generate episomal transfectants using the intact plasmid, or it may be integrated by homologous recombination into the SSU rRNA locus after digestion with SwaI to expose homologous ends. Red arrows represent ORFs of genes coding for selectable markers (resistance to ampicillin and phleomycin) and the FKBP dd. Blue depicts intergenic regions that drive expression of the dd-tagged protein and phleomycin resistance drug marker. Black arrows represent fragments of SSU locus that are used for homologous recombination to generate integrated transfectants with high protein expression levels. SMB3225  GGATCC GCCACCATGGGAG  SMB3226  GGATCCCCACCATGGTGAGCAAGGGCGAGGAG  SMB3227  GGATCCGAGTTAGTCGAGTGCGTAGTCTGGTAC  SMB3250  TGATCACCACCATGGGAGTGCAGG  SMB3251  AGATCTGGATCCTTCCGGTTTTAGAAGCTCCACATC  SMB3543  AGATCTATGGAAGACGCCAAAAACAT  SMB3130  TTAGATCTTTACACGGCGATCTTTCCGC  SMB3573  GGATCCATGGCCACCCGGAAGCTGCA  SMB3574  GGATCCTTACGAAAGACCCACAATCC  SMB3575  GGATCCATGCCGTCTGCTCAGATCAT  SMB3576  GGATCCCTATGATACGCCCAACGCAG  SMB3494  GGATCCACCATGtacccatacgatgttccagattacgctAGCGCTGACAAGGTGGTCATAATC  SMB2180  GCATGCGGATCCTACGAGGCCGTCGACGACCATGTGCA  SMB3464  GGATCCATGTCCAGGGCAGCTGCGAGGTT  SMB3465 GGATCCCTATACGGCCATCTCCATCTTGA1 Primers used to construct the gene replacement knockout cassette for L. major GLF 
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